Diagnostics services company Thyrocare Technologies reported a 12% Q-o-Q increase in revenues to Rs. 165 Cr in Q1FY22 and a 49% Y-o-Y increase in Profit after Tax to Rs. 55.87 Cr. The growth in revenues was driven by increased testing during the Covid second wave which was rampant in the country during the quarter.